Ducommun CFO Sells $145‑Share Block Amid Restatement‑Triggered Clawback Policy, Raising Insider‑Trading Spotlight

Insider Selling in the Wake of a Restatement: What Ducommun’s CFO Is Signaling

On May 20, 2026, Ducommun Inc.’s senior finance officer, Mookerji Suman B., sold 1,514 shares of common stock at $145.00 a share – the exact price that matched the market on the day of the transaction. The sale was executed to satisfy obligations under the company’s Second Amended and Restated Clawback Policy, which was invoked after a recent restatement of Ducommun’s financial statements. The move reflects a broader pattern of insider activity in the past week: the CFO has been buying and selling in rapid succession, and the company’s CEO, Oswald Stephen G., has also executed two sizable sales. While the CFO’s shares now total 25,769, his recent trading activity indicates a willingness to adjust his stake in response to corporate developments.

Implications for Investors and the Business Outlook

The CFO’s sale, tied directly to the clawback policy, underscores a lingering risk that the restated earnings may still be under scrutiny. For investors, it serves as a reminder that the company’s financial statements may carry material uncertainty, especially given Ducommun’s negative P/E ratio of –74.1 and its exposure to the cyclical aerospace and defense industry. At the same time, the market’s modest 0.43 % weekly gain and a 5.59 % monthly rise suggest that short‑term sentiment remains resilient, albeit with a slight negative social media tone (sentiment = 0) and a surge in buzz (168 % higher than average). This combination of cautious insider behavior and steady stock performance indicates that Ducommun’s leadership is managing the fallout while maintaining confidence in its long‑term product pipeline.

Mookerji Suman B.: A Transaction‑Driven CFO

Over the past six months, the CFO has traded over 20,000 shares, alternating between large‑volume sales and sizeable purchases. His most recent 20‑day window shows a net outflow of approximately 4,000 shares, yet he continues to hold a 25,769‑share position – roughly 1.2 % of the outstanding shares. The pattern of buying around $40–$151 per share and selling near $145–$151 suggests a disciplined approach to capital allocation: he sells when the stock trades near its recent high, then reinvests when the price dips. Such behavior is common among insiders who balance liquidity needs with a long‑term stake in the company, especially when clawback provisions and restatement issues create periodic cash requirements.

What Should Watchful Investors Do?

1. Monitor Clawback Activity – The CFO’s recent sale was part of the clawback policy, which may re‑emerge if further restatement adjustments are required. A spike in clawback‑related trades could signal additional earnings corrections.

2. Track Market‑Driven Moves – The CEO’s concurrent sales indicate that senior management may be hedging risk or reallocating wealth. If such selling continues, it could put downward pressure on the stock, especially given the negative earnings outlook.

3. Assess Product Pipeline – Ducommun’s core aerospace and defense contracts provide a cushion against short‑term volatility. Investors should weigh the company’s long‑term supply contracts against its current valuation, which is well below its 52‑week high.

4. Stay Informed on ESG Reporting – The Rule 13p‑1 filing highlights the company’s responsible mineral sourcing, a growing concern for defense contractors. Positive progress here could enhance investor confidence and support a higher valuation.

In sum, the CFO’s recent sale is a routine, policy‑driven move that does not necessarily signal a loss of confidence. However, it does remind investors to keep a close eye on insider activity, clawback provisions, and the company’s financial disclosures as Ducommun navigates the aftermath of its restatement.